Korro Bio, Inc. (KRRO) Stock Analysis & Investment Frameworks
Korro Bio, Inc. (KRRO) stock analysis on Invetso. Review Korro Bio, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Korro Bio, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Korro Bio, Inc. Key Financial Metrics
- Market Cap: $136.80M
- Revenue: $6.39M
- ROE: -114.26%
- ROIC: -49.21%
- Dividend Yield: N/A
About Korro Bio, Inc.
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
Korro Bio, Inc. Investment Frameworks
Invetso analyzes Korro Bio, Inc. (KRRO) across the following frameworks:
- Korro Bio, Inc. 10Y Growth Potential
- Korro Bio, Inc. Scenario Analysis
- Korro Bio, Inc. Risks & Opportunities
- Korro Bio, Inc. Economic Moat
- Korro Bio, Inc. Business Model
- Korro Bio, Inc. Management
- Korro Bio, Inc. SWOT Analysis
- Korro Bio, Inc. Porter's 5 Forces
- Korro Bio, Inc. PESTLE Analysis
- Korro Bio, Inc. ESG Analysis